
ShockWave Medical SWAV
Quarterly report 2024-Q1
added 05-06-2024
ShockWave Medical DPO Ratio 2011-2026 | SWAV
Annual DPO Ratio ShockWave Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.8 | 28.8 | 22 | 37 | 59.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 59.3 | 22 | 35.4 |
Quarterly DPO Ratio ShockWave Medical
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27 | 36.7 | 44.6 | 38.5 | - | 22.3 | 37.5 | 42.4 | - | 26.1 | 29.2 | 30 | - | 25.4 | 37.2 | 34.4 | - | 57.9 | 61.6 | 63.5 | - | 68.8 | 115 | 85.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 115 | 22.3 | 46.5 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.13 | 1.55 % | $ 1.64 B | ||
|
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
ClearPoint Neuro
CLPT
|
33.2 | $ 9.5 | 4.74 % | $ 269 M | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
46.4 | $ 39.25 | 7.04 % | $ 5.85 K | ||
|
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
47.8 | $ 23.78 | - | $ 201 M | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
Globus Medical
GMED
|
33.1 | $ 93.34 | 3.67 % | $ 12.6 B | ||
|
FONAR Corporation
FONR
|
16.6 | $ 18.61 | 0.13 % | $ 122 M | ||
|
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.59 | 5.73 % | $ 134 M | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.8 | 5.04 % | $ 755 M | ||
|
Align Technology
ALGN
|
33.7 | $ 179.16 | 7.37 % | $ 13.4 B | ||
|
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
34.4 | $ 32.65 | 5.36 % | $ 1.5 B | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
71.9 | $ 1.06 | 2.43 % | $ 18 M | ||
|
Integer Holdings Corporation
ITGR
|
28.9 | $ 87.31 | 2.58 % | $ 3.03 B | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 16.35 | 3.74 % | $ 384 M | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
LENSAR
LNSR
|
146 | $ 5.73 | 1.78 % | $ 68.5 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
76.2 | $ 87.15 | 0.8 % | $ 112 B | ||
|
Butterfly Network
BFLY
|
51.3 | $ 4.3 | 5.79 % | $ 910 M | ||
|
Myomo
MYO
|
34.8 | $ 0.67 | -0.89 % | $ 28 M | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Helius Medical Technologies
HSDT
|
362 | $ 1.9 | 3.82 % | $ 1.15 M | ||
|
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M | ||
|
Cytosorbents Corporation
CTSO
|
107 | $ 0.65 | 6.57 % | $ 40.5 M | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
56 | $ 9.88 | 2.17 % | $ 354 M | ||
|
Boston Scientific Corporation
BSX
|
61.7 | $ 62.76 | 1.47 % | $ 92.9 B | ||
|
Alphatec Holdings
ATEC
|
73.8 | $ 11.57 | 4.85 % | $ 1.74 B | ||
|
CONMED Corporation
CNMD
|
57.3 | $ 36.33 | 5.09 % | $ 1.13 B | ||
|
Insulet Corporation
PODD
|
22.5 | $ 207.36 | 2.42 % | $ 14.6 B |